CliffBio
small molecule

SODIUM NITROPRUSSIDE

SODIUM NITROPRUSSIDE

Loss of exclusivity—loss of exclusivity
CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM NITROPRUSSIDE
Active ingredientSODIUM NITROPRUSSIDE
Strength25MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusRX

More from Nexus Labs

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SODIUM NITROPRUSSIDE patent cliff — loss of exclusivity — | CliffBio